Orchid Pharma

Orchid Pharma Limited is a prominent company in the Cephalosporin pharmaceuticals segment, driving its sales through life-saving Active Pharmaceutical Ingredients (APIs) used to fight infections. The company's vision is to evolve into a composite and meaningfully integrated pharmaceutical corporation, competing in specialized areas to generate greater, more sustainable value. Its integrated business model empowers the company to leverage opportunities across the pharmaceutical value chain, from initial research to the global delivery of therapeutic products. The company manufactures and exports all five generations of cephalosporin products, including sterile and veterinary items, for various international markets. Through strategic alliances, Orchid Pharma enhances its market reach, which enables the delivery of superior quality products while also securing improved margins for its operations. As a testament to its innovation, Orchid is distinguished as the only Indian Pharmaceutical Company to have invented a New Chemical Entity approved in both the US and Europe.;